Prior and delayed applications of dizocilpine or ethanol alter locomotor sensitization to morphine

Brain Research

Volumn 878, Issue 1-2, 2000, Pages 20-31

  Kosten, Therese A ^a   Bombace, Joan C ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b QUINNIPIAC UNIVERSITY   (United States)

Author keywords

Glutamate; MK 801; NMDA; Opiates; Plasticity; Temporal dynamics

Indexed keywords

ALCOHOL; DIZOCILPINE; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; LOCOMOTION; NONHUMAN; PLASTICITY; PRIORITY JOURNAL; RAT;

ANIMAL; COMPARATIVE STUDY; DIZOCILPINE MALEATE; ETHANOL; EXCITATORY AMINO ACID ANTAGONISTS; MORPHINE; MOTOR ACTIVITY; RATS; RATS, SPRAGUE-DAWLEY; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TIME FACTORS;

EID: 0034730680     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(00)02667-6     Document Type: Article

References (55)

1. Adams J.U., Holtzman S.G. Pharmacologic characterization of the sensitization to the rate-decreasing effects of naltrexone induced by acute opioid pretreatment in rats. J. Pharmacol. Exp. Ther. 253:1990;483-489.
2. Allan A., Harris R. Acute and chronic ethanol treatments alter gaba receptor-operated chloride channels. Pharmacol. Biochem. Behav. 27:1987;665-670.
3. Babbini M., Davis W. Time-dose relationships for locomotor activity effects of morphine after acute or repeated treatment. Br. J. Pharmacol. 46:1972;213-224.
4. Bell R., Olson R.D., Vaccarino A.J. Tolerance to ethanol analgesia is not accompanied by cross-tolerance to morphine analgesia in rats. Pharmacol. Biochem. Behav. 59:1998;123-127.
5. Ben-Eliyahu S., Marek P., Vaccarion A.L., Mogil J.S., Sternberg W.F., Liebeskind J.C. The NMDA receptor antagonist MK-801 prevents long-lasting non-associative morphine tolerance in the rat. Brain Res. 575:1992;304-308.
6. Bespalov A.Y., Dumpis M., Piotrovsky L., Zvartau E.E. Excitatory amino acid receptor antagonist kynurenic acid attenuates rewarding potential of morphine. Eur. J. Pharmacol. 264:1994;233-239.
7. Bespalov A.Y., Zvartau E.E. Intraaccumbens administration of NMDA receptor antagonist (±)-CPP prevents locomotor activation conditioned by morphine and amphetamine in rats. Pharmacol. Biochem. Behav. 55:1996;203-207.
8. Carlezon W.A., Wise R.A. Morphine-induced potentiation of brain stimulation reward is enhanced by MK-801. Brain Res. 620:1993;339-342.
9. Cestari V., Castellano C. MK-801 potentiates morphine-induced impairment of memory consolidation in mice: involvement of dopaminergic mechanisms. Psychopharmacology. 133:1997;1-6.
10. Collingridge G.L., Bliss T.V.P. NMDA receptors - their role in long term potentiation. Trends Neurosci. 10:1987;288-293.
11. Fog R. Behavioral effects in rats of morphine and amphetamine and of a combination of the two drugs. Psychopharmacologia. 16:1969;305-312.
12. Fundytus M.E., Coderre T.J. Effect of activity at metabotropic, as well as ionotropic (NMDA), glutamate receptors on morphine dependence. Br. J. Pharmacol. 113:1994;1215-1220.
13. Gellert V.F., Sparber S.B. A comparison of the effects of naloxone upon body weight loss and suppression of fixed-ratio operant behavior in morphine-dependent rats. J. Pharmacol. Exp. Ther. 201:1977;44-54.
14. Grant K.A., Valverius P., Hudspith M., Tabakoff B. Ethanol withdrawal seizures and the NMDA receptor complex. Eur.J. Pharmacol. 176:1990;289-296.
15. Grant K.A. Emerging neurochemical concepts in the actions of ethanol at ligand-gated ion channels. Behav. Pharmacol. 5:1994;383-404.
16. Grant K.A., Colombo G. Discriminative stimulus effects of ethanol: effect of training dose on the substitution of N-Methyl-D-aspartate antagonists. J. Pharmacol. Exp. Ther. 264:1992;1241-1247.
17. Grass S., Hoffmann O., Xu X.J., Wiesenfel-Hallin Z. N-methyl-D-aspartate receptor antagonists potentiate morphine's antinociceptive effect in the rat. Acta Physiol. Scand. 1158:1996.
18. Hill M.P., Brotchie J.M. Modulation of glutamate release by a kappa-opioid receptor agonist in rodent and primate striatum. Eur. J. Pharmacol. 281:1995.
19. Hoffman P.L., Rabe C.S., Moses F., Tabakkoff B. N-Methyl-D-aspartate receptors and ethanol: inhibition of calcium flux and cyclic GMP production. J. Neurochem. 52:1989;1937-1940.
20. Huang N., Tseng C., Wong C., Tung C. Effects of acute and chronic morphine on DOPAC and glutamate at subcortical DA terminals in awake rats. Pharmacol. Biochem. Behav. 56:1997;363-371.
21. Jeziorski M., White F., Wolf M.E. MK-801 prevents the development of behavioral sensitization during repeated morphine administration. Synapse. 16:1994;137-147.
22. Kalivas P.W., Alesdatter J.E. Involvement of N-Methyl-D-Asparate receptor stimulation in the ventral tegmental area and amygdala in behavioral sensitization to cocaine. J. Pharmacol. Exp. Ther. 267:1993;486-495.
23. Kalivas P.W., Stewart J. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res. Rev. 16:1991;223-244.
24. Karler R., Calder L.D., Chaudhry I.A., Turkanis S.A. Blockade of 'reverse tolerance' to cocaine and amphetamine by MK-801. Life Sci. 45:1989;599-606.
25. Kosten T.A., Miserendino M.J.D., Chi S., Nestler E.J. Fischer and Lewis rat strains show differential cocaine effects in conditioned place preference and behavioral sensitization but not in locomotor activity or conditioned taste aversion. J. Pharmacol. Exp. Ther. 269:1994;137-144.
26. Larcher A., Laulin J.P., Celerier E., LeMoal M., Simonnet G. Acute tolerance associated with a single opiate administration: involvement of N-Methyl-D-Aspartate-dependent pain facilitatory systems. Neuroscience. 84:1998;583-589.
27. LeGreves P., Huang W., Zhou Q., Thornwall M., Nyberg F. Acute effects of morphine on the expression of mRNAs for NMDA receptor subunits in the rat hippocampus, hypthalamus and spinal cord. Eur. J. Pharmacol. 341:1998;161-164.
28. Livezey R.T., Pearce L.B., Kornetsky C. The effect of MK-801 and SCH23390 on the expression and sensitization of morphine-induced oral stereotypy. Brain Res. 692:1995;93-98.
29. Lovinger D., White G., Weight F. NMDA receptor mediated synaptic excitation selectively inhibited by ethanol in hippocampal slice from adult rat. Eur. J. Pharmacol. 1991:1992;469-472.
30. Madison D.V., Malenka R.C., Nicoll R.A. Mechanisms underlying long-term potentiation of synaptic transmission. Annu. Rev. Neurosci. 14:1991;379-397.
31. Marek P., Ben-Eliyahu S., Vaccarino A., Liebeskind J. Delayed application of MK-801 attenuates development of morphine tolerance in rats. Brain Res. 558:1991;163-165.
32. Nestby P., Van der Schuren L.M.J.M., DeVries T., Hogenboom F., Wardeh G., Mulder A.H., Schoffelmeer A.N.M. Ethanol, like psychostimulants and morphine, causes long-lasting hyperreactivity of dopamine and acetylcholine neurons of rat nucleus accumbens: possible role in behavioural sensitization. Psychopharmacology. 133:1997;69-76.
33. Overton D.A. Comparison of ethanol, pentobarbital, and phenobarbital using drug vs. drug discrimination training. Psychopharmacology. 53:1977;195-199.
34. Piazza P.V., Deminiere J.-M., LeMoal M., Simon H. Factors that predict individual vulnerability to amphetamine self-administration. Science. 245:1989;1511-1513.
35. Pudiak C., Bozarth M. L-NAME and MK-801 attenuate sensitization to the locomotor stimulating effect of cocaine. Life Sci. 53:1993;1517-1524.
36. Pulvirenti L., Swerdlow N.R., Koob G.F. Nucleus accumbens NMDA antagonist decreases locomotor activity produced by cocaine, heroin or accumbens dopamine, but not caffeine. Pharmacol. Biochem. Behav. 40:1991;841-845.
37. Robinson T.E., Becker J.B. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res. Rev. 11:1986;157-198.
38. Robinson T.E., Berridge K.C. The neural basis of drug craving: an incentive sensitization theory of addiction. Brain Res. Rev. 18:1993;247-291.
39. Schulteis G., Heyser C.J., Koob G.F. Opiate withdrawal signs precipitated by naloxone following a single exposure to morphine: potentiation with a second morphine exposure. Psychopharmacology. 129:1997;56-65.
40. Shoemaker W.J., Kosten T.A., Muly S. Ethanol attenuation of morphine dependence: comparison to dizocilpine. Psychopharmacology. 134:1997;83-87.
41. Stewart J., Druhan J.P. Development of both conditioning and sensitization of the behavioral activating effects of amphetamine is blocked by the non-competitive NMDA receptor antagonist, MK-801. Psychopharmacology. 110:1993;125-132.
42. Ticku M.K. Alcohol and GABA-benzodiazepine receptor function. Ann. Med. 22:1990;241-246.
43. Tiseo P., Cheng J., Pasternak G.W., Inturrisi C.E. Modulation of morphine tolerance by the competitive N-Methyl-D-Aspartate receptor antagonist LY274614: Assessment of opioid receptor changes. J. Pharmacol. Exp. Ther. 268:1994;195-201.
44. Trujillo K.A., Akil H. Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science. 251:1991;85-87.
45. Trujillo K.A., Akil H. The NMDA receptor antagonist MK-801 increases morphine catalepsy and lethallity. Pharmacol. Biochem. Behav. 38:1991;673-675.
46. Tzschentke T.M., Schmidt W.J. Morphine-induced catalepsy is augmented by NMDA receptor antagonists, but is partially attenuated by an AMPA receptor antagonist. Eur. J. Pharmacol. 295:1996;137-146.
47. Tzschentke T.M., Schmidt W.J. Interactions of MK-801 and GYKI 52466 with morphine and amphetamine in place preference conditioning and behavioural sensitization. Behav. Brain Res. 84:1997;99-107.
48. Ujike H., Tsuchida H., Kanzaki A., Akiyama K., Otsuki S. Competitive and noncompetitive N-methyl-D-aspartate antagonists fail to prevent the induction of methamphetamine-induced sensitization. Life Sci. 50:1992;1673-1681.
49. Van der Schuren L.J.M.J., Schoffelmeer A.N.M., DeVries T. Does dizocilpine (MK-801) inhibit the development of morphine-induced behavioural sensitization in rats? Life Sci. 61:1997;PL427-433.
50. 2+ uptake and glutamate release in rat cerebral cortex in primary culture. J. Neurochem. 68:1997;517-524.
51. Winer B.J. Statistical Principles in Experimental Design. 2nd Edition :1962;McGraw-Hill, New York.
52. Wolf M.E. The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants. Prog. Neurobiol. 54:1998;679-720.
53. Wolf M.E., Jeziorski M. Coadministration of MK-801 with amphetamine, cocaine or morphine prevents rather than transiently masks the development of behavioral sensitization. Brain Res. 613:1993.
54. Wolf M.E., Khansa M.R. Repeated administration of MK-801 produces sensitization to its own locomotor stimulant effects but blocks sensitization to amphetamine. Brain Res. 562:1991;164-168.
55. Woodward J.J., Gonzales R.A. Ethanol inhibition of N-methyl-D-aspartate stimulated endogenous dopamine release from rat striatal slice: reversal by glycine. J. Neurochem. 54:1990;712-715.